Phase 3 Interstitial Lung Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are 18 years of age or older
• People who have been diagnosed with Idiopathic Pulmonary Fibrosis (IPF) — a specific type of lung scarring disease — based on 2018 international medical guidelines
• People who have experienced a sudden, rapid worsening of their IPF (known as an "acute exacerbation"), confirmed or suspected based on international medical criteria, which generally includes: a sudden increase in breathlessness lasting less than one month, new findings on a chest CT scan, and worsening that is not caused by heart failure or excess fluid — people missing a CT scan may still qualify as a "suspected" case (confirm with trial site)
• Women who are able to become pregnant must be using a reliable form of contraception throughout the study (one with a failure rate of less than 1% per year when used correctly and consistently)
• People who are covered by social security (this appears to be a French social insurance requirement — confirm with trial site)
• People who are able to read and sign a consent form, or whose legal representative is able to do so on their behalf if they are unable to

Who may not be able to join:

• People whose sudden lung worsening has a known cause, such as an infection
• People with a known allergy or sensitivity to corticosteroids (steroid medications) or any ingredient in the study treatment
• People who need a breathing machine (mechanical ventilation) or are already on one
• People with an active bacterial, viral, fungal, or parasitic infection — note that only certain viruses (COVID-19, Influenza A, Influenza B, and RSV) are considered active viral infections for this trial's purposes; other viruses such as rhinovirus or adenovirus are not (confirm with trial site)
• People with an active cancer diagnosis
• People who are currently on a waiting list for a lung transplant
• People who have been taking high-dose steroid medication (more than 1 mg per kilogram of body weight per day) for more than 7 days within the past 15 days
• People who are already taking part in another clinical trial that involves a treatment intervention
• People who are pregnant or breastfeeding
• People who are under legal guardianship or supervised legal protection
• People who are not free to make their own decisions (for example, those who are detained)
• People who are under court-ordered legal protection

Important: Always verify eligibility with the trial site directly before applying.